Quadrature Capital’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-17,393
Closed -$1.52M – 1575
2025
Q4
$1.52M Buy
+17,393
New +$1.32M 0.02% 417
2024
Q3
– Sell
-14,016
Closed -$960K – 1126
2024
Q2
$960K Sell
14,016
-1,212
-8% -$72.4K 0.02% 457
2024
Q1
$817K Sell
15,228
-21,873
-59% -$1.18M 0.01% 540
2023
Q4
$1.98M Sell
37,101
-30,795
-45% -$1.5M 0.04% 252
2023
Q3
$3.37M Buy
+67,896
New +$3.8M 0.07% 189
2021
Q1
– Sell
-10,417
Closed -$680K – 982
2020
Q4
$680K Buy
+10,417
New +$599K 0.03% 401
2020
Q3
– Sell
-5,558
Closed -$265K – 803
2020
Q2
$265K Sell
5,558
-6,685
-55% -$322K 0.03% 510
2020
Q1
$521K Sell
12,243
-2,739
-18% -$135K 0.12% 227
2019
Q4
$882K Buy
+14,982
New +$813K 0.03% 289
2019
Q3
– Sell
-29,947
Closed -$1.27M – 601
2019
Q2
$1.27M Buy
+29,947
New +$1.3M 0.08% 197
2018
Q3
– Sell
-33,689
Closed -$1.7M – 651
2018
Q2
$1.7M Buy
33,689
+29,093
+633% +$1.52M 0.16% 146
2018
Q1
$229K Buy
+4,596
New +$216K 0.02% 533
2017
Q2
– Sell
-13,160
Closed -$390K – 640
2017
Q1
$390K Buy
+13,160
New +$359K 0.03% 462

Other funds holding GMED

Quadrature Capital's GMED Position: Q1 2026 in Review

Quadrature Capital sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 17,393 shares — an estimated $1.52M sold.

Quadrature Capital first reported a position in GMED in Q1 2017 and held it in 13 quarters. The position peaked at $3.37M in Q3 2023. 610 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Quadrature Capital reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 17,393 Globus Medical shares in Q1 2026, an estimated $1.52M.
  • Quadrature Capital first reported a position in Globus Medical in Q1 2017 and held it in 13 quarters.
  • Quadrature Capital's Globus Medical position peaked at $3.37M in Q3 2023.
  • 610 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.